+34 9340006100 -ext. 437807-info@nanbiosis.com

Singular

Singular

U20-S02. Animal models in oncology (Remote) OUTSTANDING

The unit/platform has strong background in oncology and counts with different type of cancer mouse models, all of them monitorable by means of bioluminescence imaging. They include subcutaneous models in a great variety of cancer types (prostate, colon, breast, pancreas, kidney, etc.) and also orthtopic and experimental metastasismodels.

The unit/platform can also set-up and validate novel xenograft models upon request.

 List of available models

  • Subcutaneous models (different cell lines and cancer types)
  • Orthotopic models:
    • Intraprostatic
    • Intramammary (i.m.f.p.)
    • Stereotactic
    • Ceccum
    • Intrapulmonar
  • Experimental metastases:
    • Intracardiac (bone metastases)
    • Intravenous (lung metastases)
    • Intraportal (liver metastases)
  • Spontaneous metastases
Read More

U20-S03. In vivo Experimental consultancy (Remote) OUTSTANDING

Planing, execution and interpretation of in vivo assays requirestime and expertise. At this unit, we give consultancy serviceson  preclinical model design, support and advice for research projects, including selection and use of the appropriate imaging system and evaluation and interpretation of the data obtained.

Read More

U20-S04. In vivo Efficay Assays of drugs, nanomedicines, biomaterials and others (Remote) OUTSTANDING

The unit/platform is specialized in oncology and lysosomal storages diseases, and several animal models are available for this type of diseases.

However, we are experienced in developing new efficacy models for testing novel nanomaterials, carriers and therapeutica compounds. Please contact us to see how we can help you in your research Project.

Read More

U20-S05. In vivo Toxicology (Onsite&Remote) OUTSTANDING

Potential target toxicity of new nanomaterials and drug delivery systems has to be carefully evaluated to support further clinical assays.  At U20 we can design, perform and evaluate all type of toxicological studies, including those toxicity analyses performed along with efficacy studiestomore specifically designed long-term or short-term toxicity assays.

Specifically, we provide full services of anatomical pathology, from sample preparation, inclusion, section and staining to anatomopathological evaluation.

Read More

U19-S01. Preclinical Studies (Onsite&Remote) OUTSTANDING

Preclinical regulatory in vivo toxicity, local and systemic tolerance and PK/PD studies; dosing of test and specimen drawing, biocompatibility studies of medical devices; Safety studies: Nervous, cardiovascular and respiratory systems.

Security testing of advanced therapies using small and large animals models.

Read More

U22-S01. Animal Housing (Remote) OUTSTANDING

It houses different animal species, whether small or big (rats, mice, rabbits, dogs, pigs, sheep, etc), in compliance with the physical and legal conditions for experimental research.

Read More

U18-S01. In vitro Nanotoxicology (Remote) OUTSTANDING

Assays of cell viability/toxicity by XTT, release of LDH and similar indicators.

  • Study of toxicity in normal human cells immortalized by viral infection or tTERT, by means of metabolic XTT test,
  • Production of reactive oxygen species (ROS ) by fluorimetry.

Internalization assays

  • Study of the mechanism of toxic action
  • Analysis of hemocompatibility in blood
Read More

U18-S02. In vivo Nanotoxicology, preclinical histopathology in animal models (Remote) OUTSTANDING

Sample preparation, inclusion, section and staining for preclinical histology (paraffin and frozen samples) as well as anatomopathological evaluation.

Complete necropsy:

  • Hematology
  • ADME/Tox of nanoparticles
  • Study of distribution of markers of interest by immunohistochemistry.
  • Study of the mechanism of toxic action (apoptosis, caspase-independent death, autophagia, necrosis).
  • Preclinical toxicity assays in animal models.

Product characterization studies, solubility and other properties studies; Inmunoassay techniques; Molecular biology techniques; Cell culture techniques; Flow cytometry; Safety studies: Nervous, cardiovascular and respiratory systems; Toxicology studies; PK/PD studies, Security testing of advanced therapies using small and large animals models.

Read More

U18-S03.  In vivo TOXICOLOGY (Onsite&Remote) OUTSTANDING

Complete necropsy:

  • Hematology
  • ADME/Tox of nanoparticles
  • Study of distribution of markers of interest by immunohistochemistry.
  • Study of the mechanism of toxic action (apoptosis, caspase-independent death, autophagia, necrosis).
  • Preclinical toxicity assays in animal models
Read More

U17-S01. Confiocal Microscopy Service (Onsite) OUTSTANDING

Spectral confocal module coupled to an inverted microscope (4 objectives: 10x, 20x, 40x and 63x) equipped with three channels of spectral detection, AOBS (“Acousto-optical beam splitter”) and resonant scanner system. Argón, He/Ne and UV lasers. Incubation cabin for cells, which allows tracking of real-time processes.

Read More